Treatment of Chronic Lymphocytic Leukemia With Pentostatin, Cyclophosphamide and Rituximab

A clinical practice guideline for patients with chronic lymphocytic leukemia. The guideline examines treatment with pentostatin, cyclophosphamide and rituximab (PCR) for patients who have undergone prior treatments including allogeneic stem cell transplant and fludarabine-based therapy. Outcomes of interest include minimized myelosupression and infection risk.